Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
|
Common Stock [Member]
Adjusted [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member]
Adjusted [Member]
|
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Total |
Balance at September 30, 2021 (in shares) at Sep. 30, 2020 |
|
120,653
|
|
|
|
|
Balance at September 30, 2021 at Sep. 30, 2020 |
|
$ 121
|
|
$ 42,055,825
|
$ (43,556,437)
|
$ (1,500,491)
|
Net loss |
|
$ 0
|
|
0
|
(6,240,482)
|
(6,240,482)
|
Stock-based compensation expense |
|
|
|
496,066
|
0
|
496,066
|
Issuance of common stock and warrants, net of financing costs (in shares) |
|
26,953
|
|
|
|
|
Issuance of common stock and warrants, net of financing costs |
|
$ 27
|
|
6,219,206
|
0
|
6,219,233
|
Vesting of restricted stock (in shares) |
|
344
|
|
|
|
|
Vesting of restricted stock |
|
$ 0
|
|
0
|
|
0
|
Balance at September 30, 2022 (in shares) at Sep. 30, 2021 |
|
147,950
|
|
|
|
|
Balance at September 30, 2022 at Sep. 30, 2021 |
|
$ 148
|
|
48,771,097
|
(49,796,919)
|
(1,025,674)
|
Net loss |
|
0
|
|
0
|
(3,387,295)
|
(3,387,295)
|
Stock-based compensation expense |
|
$ 0
|
|
397,470
|
0
|
397,470
|
Vesting of restricted stock (in shares) |
|
172
|
|
|
|
|
Vesting of restricted stock |
|
$ 0
|
|
0
|
0
|
0
|
Balance at September 30, 2022 (in shares) at Jun. 30, 2022 |
|
148,122
|
|
|
|
|
Balance at September 30, 2022 at Jun. 30, 2022 |
|
$ 148
|
|
49,168,567
|
(53,184,214)
|
(4,015,499)
|
Balance at September 30, 2021 (in shares) at Sep. 30, 2021 |
|
147,950
|
|
|
|
|
Balance at September 30, 2021 at Sep. 30, 2021 |
|
$ 148
|
|
48,771,097
|
(49,796,919)
|
(1,025,674)
|
Net loss |
|
$ 0
|
|
0
|
(5,275,854)
|
(5,275,854)
|
Stock-based compensation expense |
|
|
|
499,584
|
0
|
499,584
|
Issuance of common stock and warrants, net of financing costs (in shares) |
|
7,979
|
|
|
|
|
Issuance of common stock and warrants, net of financing costs |
|
$ 8
|
|
1,609,133
|
0
|
1,609,141
|
Vesting of restricted stock (in shares) |
|
250
|
|
|
|
|
Vesting of restricted stock |
|
$ 0
|
|
0
|
0
|
0
|
Balance at September 30, 2022 (in shares) at Sep. 30, 2022 |
156,592
|
156,179
|
|
|
|
|
Balance at September 30, 2022 at Sep. 30, 2022 |
$ 156
|
$ 156
|
$ 50,879,814
|
50,879,814
|
(55,072,773)
|
(4,192,803)
|
Balance at September 30, 2021 (in shares) at Mar. 31, 2022 |
|
148,075
|
|
|
|
|
Balance at September 30, 2021 at Mar. 31, 2022 |
|
$ 148
|
|
49,077,812
|
(52,137,384)
|
(3,059,424)
|
Net loss |
|
|
|
|
(1,046,830)
|
(1,046,830)
|
Stock-based compensation expense |
|
|
|
90,755
|
|
90,755
|
Vesting of restricted stock (in shares) |
|
47
|
|
|
|
|
Vesting of restricted stock |
|
$ 0
|
|
0
|
0
|
0
|
Balance at September 30, 2022 (in shares) at Jun. 30, 2022 |
|
148,122
|
|
|
|
|
Balance at September 30, 2022 at Jun. 30, 2022 |
|
$ 148
|
|
49,168,567
|
(53,184,214)
|
(4,015,499)
|
Balance at September 30, 2021 (in shares) at Sep. 30, 2022 |
156,592
|
156,179
|
|
|
|
|
Balance at September 30, 2021 at Sep. 30, 2022 |
$ 156
|
$ 156
|
$ 50,879,814
|
50,879,814
|
(55,072,773)
|
(4,192,803)
|
Net loss |
|
0
|
|
0
|
(4,525,640)
|
(4,525,640)
|
Stock-based compensation expense |
|
$ 0
|
|
213,809
|
0
|
213,809
|
Issuance of common stock and warrants, net of financing costs (in shares) |
|
2,526
|
|
|
|
|
Issuance of common stock and warrants, net of financing costs |
|
$ 3
|
|
440,325
|
0
|
$ 440,328
|
Exchange of warrants into common stock (in shares) |
|
1,508
|
|
|
|
0
|
Exchange of warrants into common stock |
|
$ 1
|
|
49,277
|
|
$ 49,278
|
Vesting of restricted stock (in shares) |
|
31
|
|
|
|
|
Vesting of restricted stock |
|
$ 0
|
|
0
|
0
|
0
|
Balance at September 30, 2022 (in shares) at Jun. 30, 2023 |
|
160,657
|
|
|
|
|
Balance at September 30, 2022 at Jun. 30, 2023 |
|
$ 161
|
|
51,583,224
|
(59,598,413)
|
(8,015,028)
|
Balance at September 30, 2021 at Dec. 31, 2022 |
|
|
|
|
|
(4,192,803)
|
Net loss |
|
|
|
|
|
(4,525,640)
|
Balance at September 30, 2022 (in shares) at Jun. 30, 2023 |
|
160,657
|
|
|
|
|
Balance at September 30, 2022 at Jun. 30, 2023 |
|
$ 161
|
|
51,583,224
|
(59,598,413)
|
(8,015,028)
|
Balance at September 30, 2021 (in shares) at Mar. 31, 2023 |
|
159,331
|
|
|
|
|
Balance at September 30, 2021 at Mar. 31, 2023 |
|
$ 159
|
|
51,389,059
|
(57,775,306)
|
(6,386,088)
|
Net loss |
|
|
|
|
(1,823,107)
|
(1,823,107)
|
Stock-based compensation expense |
|
|
|
41,259
|
0
|
41,259
|
Issuance of common stock and warrants, net of financing costs (in shares) |
|
1,326
|
|
|
|
|
Issuance of common stock and warrants, net of financing costs |
|
$ 2
|
|
152,906
|
0
|
152,908
|
Exchange of warrants into common stock (in shares) |
|
0
|
|
|
|
|
Exchange of warrants into common stock |
|
$ 0
|
|
0
|
0
|
0
|
Balance at September 30, 2022 (in shares) at Jun. 30, 2023 |
|
160,657
|
|
|
|
|
Balance at September 30, 2022 at Jun. 30, 2023 |
|
$ 161
|
|
$ 51,583,224
|
$ (59,598,413)
|
$ (8,015,028)
|